Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Laura J. van 't Veer
Based on 29 articles published since 2009
(Why 29 articles?)
||||
Expertise Level
The expertise of Laura J. van 't Veer ranks in the
  • Top 0.51%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 29 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases van 't Veer, Laura   ·   van 't Veer, L J   ·   van 't Veer, L   ·   van 't Veer, Laura J   ·   Van 't Veer, Laura J   ·   Van 't Veer, Laura
Work Locations
Details
Most likely:    University of California San Francisco   Contact    
2019
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Breast Surgical Oncology, Showa University, Tokyo, Japan. · Department of Breast Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. · School of Medicine, Sigmund Freud University, Vienna, Austria. · The State Key Laboratory of Genetic Engineering, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. · Ministry of Education Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. · Department of Urology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China. · Pubmed 31160710
2018
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · Pubmed 28929359
  • Robert A. Hiatt ( ) is chair of and a professor in the Department of Epidemiology and Biostatistics, director of population sciences, and associate director of the Helen Diller Family Comprehensive Cancer Center, all at the University of California, San Francisco (UCSF). · Amanda Sibley is initiatives program director at the Helen Diller Family Comprehensive Cancer Center, UCSF. · Laura Fejerman is an associate professor in the Department of Medicine, UCSF. · Stanton Glantz is a professor of medicine in the Department of Medicine and director of the Center for Tobacco Control Research and Education, UCSF. · Tung Nguyen is a professor of medicine in the Department of Medicine, UCSF. · Rena Pasick is a professor of medicine in the Department of Medicine and director of community engagement at the Helen Diller Family Comprehensive Cancer Center, UCSF. · Nynikka Palmer is an assistant professor of medicine in the Department of Medicine at UCSF. · Arnold Perkins is chair of the Community Advisory Board, Helen Diller Family Comprehensive Cancer Center, UCSF. · Michael B. Potter is a professor in the Department of Family and Community Medicine, UCSF. · Ma Somsouk is an associate professor in the Department of Medicine, UCSF. · Roberto A. Vargas is a navigator at the Clinical and Translational Science Institute, UCSF. · Laura J. van 't Veer is a leader in the Breast Oncology Program, director of Applied Genomics, and the Angela and Shu Kai Chan Endowed Chair in Cancer Research, all at the UCSF Helen Diller Family Comprehensive Cancer Center. · Alan Ashworth is president of the Helen Diller Family Comprehensive Cancer Center and senior vice president for cancer services at UCSF Health. · Pubmed 29309234
2017
  • Department of Medicine, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 9411, USA. · Rutgers New Jersey Medical School, Public Health Research Institute, Rutgers, The State University of New Jersey, 225 Warren Ave, Newark, NJ, USA. · Department of Pathology, University of California, San Francisco, CA, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. · Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Patient advocate University of California, San Francisco Breast Science Advocacy Core, San Francisco, CA, USA. · Department of Bioengineering & Therapeutic Sciences, University of California San Francisco, San Francisco, USA. · Department of Clinical Pharmacy, Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, NKI-AVL, Amsterdam, The Netherlands. · Department of Medicine, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 9411, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology Oncology, University of Minnesota, Minneapolis, MN, USA. · Pubmed 28893315
  • Department of Laboratory Medicine, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Department of Surgery, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA, 94945, USA. · Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Stockholm, Sweden. · Department of Medicine, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, Sandbäcksgatan 7, 581 83, Linköping, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Z1:00, 171 76, Stockholm, Sweden. · Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Stockholm, Sweden. · Pubmed 28776283
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco. · Buck Institute for Research on Aging, Novato, California. · Center for Comparative Medicine, University of California-Davis, Davis. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill. · Department of Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. · Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Linköping University, Linköping, Sweden. · Department of Biosciences and Nutrition, Karolinska Institutet and University Hospital, Stockholm, Sweden. · Pubmed 28662222
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Stanford Children's Health Center, Lucile Packard Children's Hospital Stanford, 401 Quarry Rd, Stanford, CA, 94305, USA. · Color Genomics, 128 Murchison Drive, Burlingame, CA, 94010, USA. · Skypax LLC, 112 Timberlyne Court, Chapel Hill, NC, USA. · University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Pubmed 28281021
  • Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Pubmed 27815749
2015
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Buck Institute for Research on Aging, Novato, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Department of Urology, University of California San Francisco, San Francisco, CA, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 26021444
2014
  • Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America. · Department of Medicine, Section of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, United States of America. · Department of Surgery, University of California San Francisco, San Francisco, California, United States of America ; Buck Institute for Research on Aging, Novato, California, United States of America. · Pubmed 24516633
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
2013
  • UCSF/Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA. Electronic address: · Pubmed 24094812
Probable:    Leeuwenhoek Hospital      
2017
  • Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Faculty of Medical Science, Anglia Ruskin University, Cambridge, UK. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Epidemiology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Laboratory Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · University of Texas, Health Sciences Center, San Antonio, USA. · Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, UK. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28412587
  • Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Laboratory for Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Pathology (Josephine Nefkens Institute), Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands. · Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands. · Department of Radiotherapy, Medisch Spectrum Twente, Enschede, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Pubmed 28376189
2016
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Comprehensive Cancer Center The Netherlands, Utrecht, The Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands. · Landspitali University Hospital, Reykjavik, Iceland; University of Iceland, School of Medicine, Reykjavik, Iceland. · Department of Clinical Genetics, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Epidemiology, University of California Irvine, Irvine, CA, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, University Kiel, Kiel, Germany. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Peter MacCallum Cancer Institute, Melbourne, VIC, Australia; Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia. · Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA. · Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany. · Centro Nacional de Genotipación, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Sheba Medical Center, Tel Aviv, Israel. · Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium. · Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway. · Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland. · Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany. · Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Section of Genetic Oncology, Department of Laboratory Medicine, University Hospital of Pisa, University of Pisa, Pisa, Italy. · Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Department of Pathology, University of Melbourne, Melbourne, VIC, Australia. · Gynaecological Oncology, The Chris O'Brien Lifehouse and The University of Sydney, Sydney, Australia. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, USA. · Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA. · Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK. · Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany. · Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK. · Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada. · Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK. · Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Clinical Genetics, Lund University, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, CA, USA. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Department of Cancer Epidemiology/Clinical Cancer Registry, Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany. · Clinical Cancer Genetics, City of Hope, Duarte, CA, USA; New Mexico Cancer Center, Albuquerque, NM, USA. · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Molecular Diagnostics Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece. · Kansas IDeA Network of Biomedical Research Excellence Bioinformatics Core, The University of Kansas Cancer Center, Kansas City, KS, USA. · University of Pennsylvania, Philadelphia, PA, USA. · The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel; Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA. · Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · GEMO Study: National Cancer Genetics Network, UNICANCER Genetic Group, France. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany; Institute of Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Research Center (DKFZ), Heidelberg, Germany. · Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, UCL, London, UK. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, UK. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. · Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA. · Gynecological Oncology Unit, The Royal Marsden Hospital, London, UK. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France. · Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating Center: Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center, Erlangen, Germany. · Clinical Cancer Genetics, City of Hope, Duarte, CA, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative Medicine, Vilnius, Lithuania. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland. · Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Jyväskylä Central Hospital, Jyväskylä, Finland. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · kConFab: Kathleen Cuningham Consortium for Research into Familial Breast Cancer - Peter MacCallum Cancer Center, Melbourne, Australia. · Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada; Department of Oncology, University of Calgary, Calgary, Alberta, Canada. · School of Medicine, National University of Ireland, Galway, Ireland. · Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), Universitetet i Oslo, Norway. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Vesalius Research Center (VRC), VIB, Leuven, Belgium. · Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France. · Pubmed 25940428
  • Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. · Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarland, Germany. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Pathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK. · Divisions of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Faculty of Medicine Academic Unit of Cancer Sciences, Southampton General Hospital, Southampton, UK. · Family Cancer Clinic, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London, UK. · Pubmed 27756439
  • Alexandra J. van den Broek, Laura J. van 't Veer, Sten Cornelissen, Annegien Broeks, Emiel J. Rutgers, Flora E. van Leeuwen, and Marjanka K. Schmidt, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam · Maartje J. Hooning and Caroline Seynaeve, Erasmus MC Cancer Institute, Rotterdam · Vincent T.H.B.M. Smit, Cees J. Cornelisse, and Rob A.E.M. Tollenaar, Leiden University Medical Center, Leiden · Mike van Beek, PAMM, Catharina Hospital, Eindhoven · Maryska L. Janssen-Heijnen, Netherlands Comprehensive Cancer Organization, Eindhoven, and VieCuri Medical Centre, Venlo · Pieter J. Westenend, Laboratory for Pathology, Dordrecht · Jan J. Jobsen, Medisch Spectrum Twente, Enschede · and Sabine Sieling, Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands. · Pubmed 26700119
2015
  • Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Surgery, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 25816289
  • 1] Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands [2] Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 25138101
2014
  • 1] Human Genetics, Genome Institute of Singapore, 60 Biopolis Street 02-01, Singapore 138672, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore, MD3, 16 Medical Drive, Singapore 117597, Singapore [3]. · 1] Department of Surgery, University of California at San Francisco (UCSF), San Francisco, California 94143, USA [2] Department of Biosciences and Nutrition, Karolinska Institutet and University Hospital, SE-171 77 Stockholm, Sweden [3]. · Human Genetics, Genome Institute of Singapore, 60 Biopolis Street 02-01, Singapore 138672, Singapore. · Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton SO16 6YD, UK. · 1] Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands [2] Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. · 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. · Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, 5th floor, West Wing, Medical Building 181, Melbourne, Victoria 3010, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Department of Health Science and Services, Graduate School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. · 1] University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany [2] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, California 90095, USA. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany. · Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Schlossplatz 4, 91054 Erlangen, Germany. · Department of Oncology, University of Helsinki and Helsinki University Central Hospital, FI-00029 HUS Helsinki, Finland. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FI-00029 Helsinki, Finland. · Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FI-00029 Helsinki, Finland. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [3] Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland. · 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland [3] Jyväskylä Central Hospital, Keskussairaalantie 19, 40620 Jyväskylä, Finland. · Department of Genetics, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Queensland 4006, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, St Andrews Place East, East Melbourne, Victoria 3002, Australia. · Department of Oncology, St Vincent's Hospital Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia. · 1] Vesalius Research Center (VRC), VIB, Herestraat 49, 3000 Leuven, Belgium [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium. · Multidisciplinary Breast Center, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. · 1] Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany [2] Department of Cancer Epidemiology/Clinical Cancer Registry, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany [3] Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, Cancer Council Victoria, 1 Rathdowne Street, Melbourne, Victoria 3053, Australia. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 San Pablo Street, Los Angeles, California 90033, USA. · University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway [3] Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Sykehusveien 25, 1478 Lørenskog, Norway. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu University Hospital, Aapistie 5A, FI-90220 Oulu, Finland. · Laboratory of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220 Oulu, Finland. · 1] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5 [2] Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8. · 1] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5 [2] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario, Canada M5T 3M7. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5. · Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5. · 1] Department of Human Genetics, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands [2] Department of Pathology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. · Molecular Genetics of Breast Cancer, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. · 1] Molecular Genetics of Breast Cancer, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany [2] Institute of Human Genetics, Pontificia University Javeriana, Carrera 7, Bogotá 11001000, Colombia. · Frauenklinik der Stadtklinik Baden-Baden, D-7570 Baden-Baden, Germany. · Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133 Karlsruhe, Germany. · 1] Institute of Biomedical Sciences, Academia Sinica, Academia Road Nankang, Taipei 115, Taiwan [2] College of Public Health, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan. · Institute of Biomedical Sciences, Academia Sinica, Academia Road Nankang, Taipei 115, Taiwan. · Taiwan Biobank, Academia Sinica, Academia Road Nankang, Taipei 115, Taiwan. · Department of Surgery, Changhua Christian Hospital, No. 135, Nanhsiao Street, Changhua 500, Taiwan. · 1] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, 1 Jalan SS 12/1A, Subang Jaya47500, Selangor, Malaysia [2] Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University Malaya, Lembah Pantai, 59100 Kuala Lumpur, Malaysia. · Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University Malaya, Lembah Pantai, 59100 Kuala Lumpur, Malaysia. · Department of Oncology, Faculty of Medicine, University Malaya, Lembah Pantai, 59100 Kuala Lumpur, Malaysia. · Department of Preventive Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden Chikusa-ku, Nagoya 464-8681, Aichi, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden Chikusa-ku, Nagoya 464-8681, Aichi, Japan. · 1] Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. · Department of Biomedical Sciences, Seoul National University Graduate School, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. · Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77 Stockholm, Sweden. · Pubmed 24937182
2014
  • Department of Surgical Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands. · Pubmed 25414025
2013
  • Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23371464
Probable:    Miscellaneous institutions in Amsterdam      
2017
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
2016
  • Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Agendia Inc, 22 Morgan, Irvine, CA 92618, USA. · Divisions of Molecular Pathology and Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Pubmed 27002507
2014
  • Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: · Department of Research and Development, Agendia, Amsterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Product Development and Support, Agendia, Amsterdam, the Netherlands. · Department of Medical Affairs, Agendia, Irvine, California. · Department of Medical Affairs, Agendia, Amsterdam, the Netherlands. · Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgical Oncology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Pathology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Medicine, Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, California. · Department of Surgery, University of South Florida, Tampa, Florida. · Pubmed 24378251
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 29 total) written by Laura J. van 't Veer about Breast Neoplasms:

  • Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities. 2019
  • Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial. 2018
  • The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer. 2018
  • Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors. 2017
  • The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting. 2017
  • Tamoxifen therapy benefit for patients with 70-gene signature high and low risk. 2017
  • Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades. 2017
  • Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years. 2017
  • Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women. 2017
  • Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. 2017
Show List of Full Article Records
Google Searches

Learn more about Laura J. van 't Veer using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of California San Francisco
Leeuwenhoek Hospital
Miscellaneous institutions in Amsterdam
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of California San Francisco
2019
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Breast Surgical Oncology, Showa University, Tokyo, Japan. · Department of Breast Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany. · School of Medicine, Sigmund Freud University, Vienna, Austria. · The State Key Laboratory of Genetic Engineering, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. · Ministry of Education Key Laboratory of Contemporary Anthropology, Collaborative Innovation Center of Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China. · Department of Urology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China. · Pubmed 31160710
2018
  • Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Medical Affairs, Agendia, Amsterdam, The Netherlands. · European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Pathology, European Institute of Oncology and University of Milan, Via Ripamonti 435, 20141, Milan, Italy. · Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. · Pubmed 28929359
  • Robert A. Hiatt ( ) is chair of and a professor in the Department of Epidemiology and Biostatistics, director of population sciences, and associate director of the Helen Diller Family Comprehensive Cancer Center, all at the University of California, San Francisco (UCSF). · Amanda Sibley is initiatives program director at the Helen Diller Family Comprehensive Cancer Center, UCSF. · Laura Fejerman is an associate professor in the Department of Medicine, UCSF. · Stanton Glantz is a professor of medicine in the Department of Medicine and director of the Center for Tobacco Control Research and Education, UCSF. · Tung Nguyen is a professor of medicine in the Department of Medicine, UCSF. · Rena Pasick is a professor of medicine in the Department of Medicine and director of community engagement at the Helen Diller Family Comprehensive Cancer Center, UCSF. · Nynikka Palmer is an assistant professor of medicine in the Department of Medicine at UCSF. · Arnold Perkins is chair of the Community Advisory Board, Helen Diller Family Comprehensive Cancer Center, UCSF. · Michael B. Potter is a professor in the Department of Family and Community Medicine, UCSF. · Ma Somsouk is an associate professor in the Department of Medicine, UCSF. · Roberto A. Vargas is a navigator at the Clinical and Translational Science Institute, UCSF. · Laura J. van 't Veer is a leader in the Breast Oncology Program, director of Applied Genomics, and the Angela and Shu Kai Chan Endowed Chair in Cancer Research, all at the UCSF Helen Diller Family Comprehensive Cancer Center. · Alan Ashworth is president of the Helen Diller Family Comprehensive Cancer Center and senior vice president for cancer services at UCSF Health. · Pubmed 29309234
2017
  • Department of Medicine, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 9411, USA. · Rutgers New Jersey Medical School, Public Health Research Institute, Rutgers, The State University of New Jersey, 225 Warren Ave, Newark, NJ, USA. · Department of Pathology, University of California, San Francisco, CA, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA. · Department of Laboratory Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. · Patient advocate University of California, San Francisco Breast Science Advocacy Core, San Francisco, CA, USA. · Department of Bioengineering & Therapeutic Sciences, University of California San Francisco, San Francisco, USA. · Department of Clinical Pharmacy, Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, NKI-AVL, Amsterdam, The Netherlands. · Department of Medicine, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 9411, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology Oncology, University of Minnesota, Minneapolis, MN, USA. · Pubmed 28893315
  • Department of Laboratory Medicine, University of California San Francisco, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Department of Surgery, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA, 94945, USA. · Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Stockholm, Sweden. · Department of Medicine, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA, 94115, USA. · Department of Clinical and Experimental Medicine and Department of Oncology, Linköping University, Sandbäcksgatan 7, 581 83, Linköping, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Z1:00, 171 76, Stockholm, Sweden. · Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Stockholm, Sweden. · Pubmed 28776283
  • Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco. · Buck Institute for Research on Aging, Novato, California. · Center for Comparative Medicine, University of California-Davis, Davis. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill. · Department of Oncology-Pathology, Karolinska Institutet and University Hospital, Stockholm, Sweden. · Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. · Department of Oncology, Linköping University, Linköping, Sweden. · Department of Biosciences and Nutrition, Karolinska Institutet and University Hospital, Stockholm, Sweden. · Pubmed 28662222
  • University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Stanford Children's Health Center, Lucile Packard Children's Hospital Stanford, 401 Quarry Rd, Stanford, CA, 94305, USA. · Color Genomics, 128 Murchison Drive, Burlingame, CA, 94010, USA. · Skypax LLC, 112 Timberlyne Court, Chapel Hill, NC, USA. · University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Pubmed 28281021
  • Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. · Pubmed 27815749
2015
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Buck Institute for Research on Aging, Novato, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Department of Urology, University of California San Francisco, San Francisco, CA, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Surgery, University of California San Francisco, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Division of Hematology/Oncology, University of California San Francisco, Box 1387, 2340 Sutter Street, San Francisco, CA, 94115, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA. · Pubmed 26021444
2014
  • Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America. · Department of Medicine, Section of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts, United States of America. · Department of Surgery, University of California San Francisco, San Francisco, California, United States of America ; Buck Institute for Research on Aging, Novato, California, United States of America. · Pubmed 24516633
2016
  • From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California · University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago · University of Pennsylvania, Philadelphia (A.D.) · Gemini Group, Ann Arbor, MI (J.P.) · University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota · Swedish Medical Center, Seattle (H.G.K.) · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Kansas, Lawrence (Q.J.K.) · University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · University of Denver, Denver (A.D.E.) · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406347
  • From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California · Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.) · University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota · M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas · Gemini Group, Ann Arbor, MI (J.P.) · University of Pennsylvania, Philadelphia (A.D.) · Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.) · Swedish Medical Center, Seattle (H.G.K.) · University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago · Inova Fairfax Hospital, Falls Church, VA (K.K.E.) · University of Denver, Denver (A.D.E.) · Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona · University of Kansas, Lawrence (Q.J.K.) · and Emory University, Atlanta (W.C.W.). · Pubmed 27406346
2013
  • UCSF/Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA. Electronic address: · Pubmed 24094812
Leeuwenhoek Hospital
2017
  • Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Faculty of Medical Science, Anglia Ruskin University, Cambridge, UK. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Epidemiology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Laboratory Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · University of Texas, Health Sciences Center, San Antonio, USA. · Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, UK. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28412587
  • Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Laboratory for Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Pathology (Josephine Nefkens Institute), Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands. · Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands. · Department of Radiotherapy, Medisch Spectrum Twente, Enschede, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Pubmed 28376189
2016
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. Electronic address: · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Comprehensive Cancer Center The Netherlands, Utrecht, The Netherlands; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands. · Landspitali University Hospital, Reykjavik, Iceland; University of Iceland, School of Medicine, Reykjavik, Iceland. · Department of Clinical Genetics, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. · Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. · Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Epidemiology, University of California Irvine, Irvine, CA, USA. · N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. · Department of Gynecology and Obstetrics, University Hospital of Schleswig-Holstein, University Kiel, Kiel, Germany. · Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Clinical Cancer Genetics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Oncology, Karolinska University Hospital, Stockholm, Sweden. · Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Cancer Division, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia; Peter MacCallum Cancer Institute, Melbourne, VIC, Australia; Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia. · Centre for Epidemiology and Biostatistics, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia. · Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead Millennium Institute for Medical Research, University of Sydney, Sydney, Australia. · Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA. · Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. · Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany. · Centro Nacional de Genotipación, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain. · Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Sheba Medical Center, Tel Aviv, Israel. · Multidisciplinary Breast Center, University Hospital Leuven, University of Leuven, Belgium. · Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway. · Department of Oncology, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland. · Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. · Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark. · Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark. · Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Epidemiology, Cancer Prevention Institute of California, Fremont, CA, USA. · Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. · Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada. · Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI-Catalan Institute of Oncology, Girona, Spain. · Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany. · Department of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA. · Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland; Department of Obstetrics and Gynecology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland. · Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA. · Section of Genetic Oncology, Department of Laboratory Medicine, University Hospital of Pisa, University of Pisa, Pisa, Italy. · Cancer Genetics Laboratory, Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia; Department of Pathology, University of Melbourne, Melbourne, VIC, Australia. · Gynaecological Oncology, The Chris O'Brien Lifehouse and The University of Sydney, Sydney, Australia. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Center for Medical Genetics, Ghent University, Ghent, Belgium. · Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. · Division of Epidemiology and Biostatistics, University of New Mexico, Albuquerque, NM, USA. · Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA. · Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK. · Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, MA, USA; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. · Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. · Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA. · International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical Academy, Szczecin, Poland. · INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France. · Molecular Oncology Laboratory, Hospital Clinico San Carlos, Madrid, Spain. · Center for Cancer Research, University of Sydney at Westmead Millennium Institute, Sydney, Australia; Department of Gynaecological Oncology, Westmead Hospital, Sydney, Australia. · Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Oncogenetics Laboratory, University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Section of Biostatistics and Epidemiology, The Geisel School of Medicine at Dartmouth, Lebanon, NH, USA. · Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Basser Research Centre, Abramson Cancer Center, The University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA. · Department of Genetics, University of Pretoria, Pretoria, South Africa. · Department of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany. · Non-Communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK. · Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Klinik Wiesbaden, Wiesbaden, Germany; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany. · Centre Hospitalier Universitaire de Québec Research Center, Laval University, Quebec, Canada. · Institute of Biology and Molecular Genetics, Universidad de Valladolid (IBGM-UVA), Valladolid, Spain. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton, UK. · Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. · Department of Clinical Genetics, Lund University, Lund, Sweden. · Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany. · Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany; David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California at Los Angeles, CA, USA. · Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL-Catalan Institute of Oncology, Barcelona, Spain. · Department of Cancer Epidemiology/Clinical Cancer Registry, Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany. · Clinical Cancer Genetics, City of Hope, Duarte, CA, USA; New Mexico Cancer Center, Albuquerque, NM, USA. · Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan, Italy; Cogentech Cancer Genetic Test Laboratory, Milan, Italy. · Molecular Diagnostics Laboratory, Institute of Nuclear & Radiological Sciences & Technology, Energy & Safety, National Centre for Scientific Research Demokritos, Aghia Paraskevi Attikis, Athens, Greece. · Kansas IDeA Network of Biomedical Research Excellence Bioinformatics Core, The University of Kansas Cancer Center, Kansas City, KS, USA. · University of Pennsylvania, Philadelphia, PA, USA. · The Susanne Levy Gertner Oncogenetics Unit, Sheba Medical Center, Tel-Hashomer, Israel; Institute of Oncology, Sheba Medical Center, Tel-Hashomer, Israel. · Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA. · Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. · GEMO Study: National Cancer Genetics Network, UNICANCER Genetic Group, France. · Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr-Universität Bochum (IPA), Bochum, Germany; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany; Institute of Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany; Cancer Research Center (DKFZ), Heidelberg, Germany. · Gynaecological Cancer Research Centre, Department of Women's Cancer, Institute for Women's Health, UCL, London, UK. · Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Cancer Research UK Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Glasgow, UK. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA. · Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA. · Gynecological Oncology Unit, The Royal Marsden Hospital, London, UK. · Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. · INSERM U1018, CESP (Center for Research in Epidemiology and Population Health), Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France. · Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA. · Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA. · Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating Center: Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander-University Erlangen-Nuremberg, Comprehensive Cancer Center, Erlangen, Germany. · Clinical Cancer Genetics, City of Hope, Duarte, CA, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. · Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · N.N. Petrov Institute of Oncology, St. Petersburg, Russia. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Vilnius University Hospital Santariskiu Clinics, Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, State Research Centre Institute for Innovative Medicine, Vilnius, Lithuania. · Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland. · Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. · Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark. · Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland. · Women's Cancer Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland; Jyväskylä Central Hospital, Jyväskylä, Finland. · Clinical Genetics Research Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · kConFab: Kathleen Cuningham Consortium for Research into Familial Breast Cancer - Peter MacCallum Cancer Center, Melbourne, Australia. · Department of Population Health Research, Alberta Health Services-Cancer Care, Calgary, Alberta, Canada; Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada; Department of Oncology, University of Calgary, Calgary, Alberta, Canada. · School of Medicine, National University of Ireland, Galway, Ireland. · Department for Health Evidence, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands. · Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. · Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), Universitetet i Oslo, Norway. · Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Belgium; Vesalius Research Center (VRC), VIB, Leuven, Belgium. · Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. · Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA. · Genetic and Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France. · Pubmed 25940428
  • Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. · Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · Centro de Investigacion en Red de Enfermedades Raras (CIBERER), Valencia, Spain. · Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne, Melbourne, Australia. · Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. · Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. · German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. · Saarland Cancer Registry, Saarland, Germany. · School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. · Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. · University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Department of Pathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. · Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. · Department of Human Genetics and Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK. · Divisions of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. · Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland. · Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. · Faculty of Medicine Academic Unit of Cancer Sciences, Southampton General Hospital, Southampton, UK. · Family Cancer Clinic, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. · Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London, UK. · Pubmed 27756439
  • Alexandra J. van den Broek, Laura J. van 't Veer, Sten Cornelissen, Annegien Broeks, Emiel J. Rutgers, Flora E. van Leeuwen, and Marjanka K. Schmidt, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam · Maartje J. Hooning and Caroline Seynaeve, Erasmus MC Cancer Institute, Rotterdam · Vincent T.H.B.M. Smit, Cees J. Cornelisse, and Rob A.E.M. Tollenaar, Leiden University Medical Center, Leiden · Mike van Beek, PAMM, Catharina Hospital, Eindhoven · Maryska L. Janssen-Heijnen, Netherlands Comprehensive Cancer Organization, Eindhoven, and VieCuri Medical Centre, Venlo · Pieter J. Westenend, Laboratory for Pathology, Dordrecht · Jan J. Jobsen, Medisch Spectrum Twente, Enschede · and Sabine Sieling, Netherlands Comprehensive Cancer Organization, Utrecht, Netherlands. · Pubmed 26700119
2015
  • Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Surgery, Leiden University Medical Centre, Leiden, Netherlands. · Pubmed 25816289
  • 1] Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands [2] Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands. · Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 25138101
2014
  • 1] Human Genetics, Genome Institute of Singapore, 60 Biopolis Street 02-01, Singapore 138672, Singapore [2] Saw Swee Hock School of Public Health, National University of Singapore, MD3, 16 Medical Drive, Singapore 117597, Singapore [3]. · 1] Department of Surgery, University of California at San Francisco (UCSF), San Francisco, California 94143, USA [2] Department of Biosciences and Nutrition, Karolinska Institutet and University Hospital, SE-171 77 Stockholm, Sweden [3]. · Human Genetics, Genome Institute of Singapore, 60 Biopolis Street 02-01, Singapore 138672, Singapore. · Faculty of Medicine, University of Southampton, University Hospital Southampton, Southampton SO16 6YD, UK. · 1] Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands [2] Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. · 1] Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK [2] Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK. · Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK. · Division of Molecular Pathology, Netherlands Cancer Institute, Postbus 90203, 1006 BE Amsterdam, The Netherlands. · Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, 5th floor, West Wing, Medical Building 181, Melbourne, Victoria 3010, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Department of Health Science and Services, Graduate School of Public Health, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. · 1] University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany [2] Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, 10833 Le Conte Avenue, Los Angeles, California 90095, USA. · University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Universitätsstrasse 21-23, 91054 Erlangen, Germany. · Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg, Schlossplatz 4, 91054 Erlangen, Germany. · Department of Oncology, University of Helsinki and Helsinki University Central Hospital, FI-00029 HUS Helsinki, Finland. · Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FI-00029 Helsinki, Finland. · Department of Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Haartmaninkatu 8, FI-00029 Helsinki, Finland. · Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE-17177, Sweden. · Department of Oncology-Pathology, Karolinska Institutet, Stockholm SE-17177, Sweden. · 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Biocenter Kuopio, Cancer Center of Eastern Finland, University of Eastern Finland, FI-70211 Kuopio, Finland [3] Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland. · 1] School of Medicine, Institute of Clinical Medicine, Oncology, University of Eastern Finland, Yliopistonranta 1C, FI-70211 Kuopio, Finland [2] Cancer Center, Kuopio University Hospital, Puijonlaaksontie 2, 70210 Kuopio, Finland [3] Jyväskylä Central Hospital, Keskussairaalantie 19, 40620 Jyväskylä, Finland. · Department of Genetics, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Queensland 4006, Australia. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Sir Peter MacCallum Department of Oncology, University of Melbourne, St Andrews Place East, East Melbourne, Victoria 3002, Australia. · Department of Oncology, St Vincent's Hospital Melbourne, 9 Princes Street, Fitzroy, Victoria 3065, Australia. · 1] Vesalius Research Center (VRC), VIB, Herestraat 49, 3000 Leuven, Belgium [2] Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Herestraat 49, 3000 Leuven, Belgium. · Multidisciplinary Breast Center, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. · Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. · 1] Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany [2] Department of Cancer Epidemiology/Clinical Cancer Registry, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany [3] Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany. · 1] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Level 1, 723 Swanston Street, Melbourne, Victoria 3010, Australia [2] Cancer Epidemiology Centre, Cancer Council Victoria, 1 Rathdowne Street, Melbourne, Victoria 3053, Australia. · Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 San Pablo Street, Los Angeles, California 90033, USA. · University of Hawaii Cancer Center, 701 Ilalo Street, Honolulu, Hawaii 96813, USA. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway [3] Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Sykehusveien 25, 1478 Lørenskog, Norway. · 1] Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, N-0310 Oslo, Norway [2] K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Kirkeveien 166, 0450 Oslo, Norway. · Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu University Hospital, Aapistie 5A, FI-90220 Oulu, Finland. · Laboratory of Oncology, Oulu University Hospital, University of Oulu, Kajaanintie 50, FI-90220 Oulu, Finland. · 1] Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5 [2] Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8. · 1] Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5 [2] Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, Ontario, Canada M5T 3M7. · Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5. · Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada M5G 1 × 5. · 1] Department of Human Genetics, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands [2] Department of Pathology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. · Department of Surgical Oncology, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. · Department of Clinical Genetics, Erasmus University Medical Center, Groene Hilledijk 301, 3075EA Rotterdam, The Netherlands. · Molecular Genetics of Breast Cancer, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. · 1] Molecular Genetics of Breast Cancer, DKFZ, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany [2] Institute of Human Genetics, Pontificia University Javeriana, Carrera 7, Bogotá 11001000, Colombia. · Frauenklinik der Stadtklinik Baden-Baden, D-7570 Baden-Baden, Germany. · Institute of Pathology, Städtisches Klinikum Karlsruhe, Moltkestrasse 90, 76133 Karlsruhe, Germany. · 1] Institute of Biomedical Sciences, Academia Sinica, Academia Road Nankang, Taipei 115, Taiwan [2] College of Public Health, China Medical University, No. 91, Hsueh-Shih Road, Taichung 40402, Taiwan. · Institute of Biomedical Sciences, Academia Sinica, Academia Road Nankang, Taipei 115, Taiwan. · Taiwan Biobank, Academia Sinica, Academia Road Nankang, Taipei 115, Taiwan. · Department of Surgery, Changhua Christian Hospital, No. 135, Nanhsiao Street, Changhua 500, Taiwan. · 1] Cancer Research Initiatives Foundation, Sime Darby Medical Centre, 1 Jalan SS 12/1A, Subang Jaya47500, Selangor, Malaysia [2] Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University Malaya, Lembah Pantai, 59100 Kuala Lumpur, Malaysia. · Breast Cancer Research Unit, Faculty of Medicine, University Malaya Cancer Research Institute, University Malaya, Lembah Pantai, 59100 Kuala Lumpur, Malaysia. · Department of Oncology, Faculty of Medicine, University Malaya, Lembah Pantai, 59100 Kuala Lumpur, Malaysia. · Department of Preventive Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. · Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden Chikusa-ku, Nagoya 464-8681, Aichi, Japan. · Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden Chikusa-ku, Nagoya 464-8681, Aichi, Japan. · 1] Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea [2] Department of Biomedical Sciences, Seoul National University Graduate School, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. · Department of Biomedical Sciences, Seoul National University Graduate School, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea. · Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Worts Causeway, Cambridge CB1 8RN, UK. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, 171 77 Stockholm, Sweden. · Pubmed 24937182
2014
  • Department of Surgical Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands. · Pubmed 25414025
2013
  • Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23371464
Miscellaneous institutions in Amsterdam
2017
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
2016
  • Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Agendia Inc, 22 Morgan, Irvine, CA 92618, USA. · Divisions of Molecular Pathology and Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Pubmed 27002507
2014
  • Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: · Department of Research and Development, Agendia, Amsterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Product Development and Support, Agendia, Amsterdam, the Netherlands. · Department of Medical Affairs, Agendia, Irvine, California. · Department of Medical Affairs, Agendia, Amsterdam, the Netherlands. · Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgical Oncology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Pathology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Medicine, Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, California. · Department of Surgery, University of South Florida, Tampa, Florida. · Pubmed 24378251
27 Other Locations Show
Yearly article counts 12864440000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.